BLOODGENETICS SL
Company details
- Active NIF/CIF: B66880998
-
-
-
-
Address: 18, Carrer Verge de Guadalupe, 1, 08950 Esplugues de Llobregat, Barcelona, España See in map
-
-
Featured products:
More information on BLOODGENETICS SL
-
05/06/2024 | BORME act no.: 253997 | Register: BARCELONAAmpliación de capital
-
28/04/2022 | BORME act no.: 188615 | Register: BARCELONAAmpliación de capital
-
07/07/2020 | BORME act no.: 207204 | Register: BARCELONAAmpliación de capital
-
04/04/2018 | BORME act no.: 149597 | Register: BARCELONAAmpliación de capital
-
04/04/2018 | BORME act no.: 149597 | Register: BARCELONAAmpliación de capital
-
04/04/2018 | BORME act no.: 149597 | Register: BARCELONACambio de domicilio social
-
09/12/2016 | BORME act no.: 496431 | Register: BARCELONAConstitución
-
09/12/2016 | BORME act no.: 496431 | Register: BARCELONANombramientos
Other information
The CIF assigned to BLOODGENETICS SL is B66880998, and its business status is active. The company is engaged in an economic activity classified within the CNAE 8622 - Specialised medicine activities. In addition, its SIC identification - also defines it.
BLOODGENETICS SL employs a team of Between 1 and 9 employees and generates an annual turnover of less than 2 million euros. The company is registered in the Mercantile Registry of Barcelona, and has 1 executive positions. Its most recent announcement in the Borme was published on 05/06/2024, while its last deposit of ordinary annual accounts is for the 2023 fiscal year.
To access the contact information of BLOODGENETICS SL, such as the telephone number, postal address, or website, visit the Company Data module.
If you require more details about BLOODGENETICS SL, we invite you to consult one of our available financial reports, the company's Annual Accounts, or to check its payment incidents in the RAI delinquency file.
The financial, business, and legal information provided about BLOODGENETICS SL is extracted from official sources and is updated daily.
Do you want to know more about BLOODGENETICS SL??
Find out more about this company by consulting these reports: